Phase III Trial Diversity Plan Template

We created a template to help you plan for diverse patient recruitment. Based on our White Paper that included:

100+Hours of interviews
14,000+Clinical Trials
100+Literature Reviews
Download template

Why Now?

The FDA now requires phase III clinical trials to have a diversity plan but as yet, the requirements are vague.

We've spoken to 5 senior diversity executives at top 20 pharmaceutical companies and built this framework to serve as a resource in building out a plan for diverse patient recruitment.

About This Template

We created a simple one-pager template to serve as a resource in building out a plan for diverse patient recruitment.

Here are the 6 areas we cover in the template:

  • Goal setting
  • Protocol design
  • Site selection and startup
  • Recruitment
  • Lifestyle barriers
  • Ongoing monitoring and analytics
Download template

Interested in the white paper, Achieving Representation in Clinical Research?

We wrote a white paper where we share 14 tactics to improve clinical trial diversity. If you work in or around clinical research and strive to improve representation in trials, this white paper is for you.

Download White Paper
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top